• 1
    Krekoukia M, Nassis GP, Psarra G et al. Elevated total and central adiposity and low physical activity are associated with insulin resistance in children. Metabolism 2007; 56: 206213.
  • 2
    Kopelman PG. Obesity as a medical problem. Nature 2000; 404: 635643.
  • 3
    Asayama K, Hayashi K, Hayashibe H et al. Relationships between an index of body fat distribution (based on waist and hip circumferences) and stature, and biochemical complications in obese children. Int J Obes Relat Metab Disord 1998; 22: 12091216.
  • 4
    Tong PC, Kong AP, So WY et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes care 2007; 30: 12061211.
  • 5
    Raitakari OT, Prorkka KV, Taimela S et al. Effects of persistent physical activity and inactivity on coronary risk factors in children and young adults. The Cardiovascular Rish in Young Finns Study. Am J Epidemiol 1994; 140: 195205.
  • 6
    Ball GD, Shaibi GQ, Cruz ML et al. Insulin sensitivity, cardiorespiratory fitness, and physical activity in overweight Hispanic youth. Obes Res 2004; 12: 7785.
  • 7
    Gutin B, Yin Z, Humphries MC et al. Relations of fatness and fitness to fasting insulin in black and white adolescents. J Pediatr 2004; 145: 737743.
  • 8
    Kasa-Vubu JZ, Lee CC, Rosenthal A, Singer K, Halter JB. Cardiovascular fitness and exercise as determinants of insulin resistance in postpubertal adolescent females. J Clin Endocrinol Metab 2005; 90: 849854.
  • 9
    Rizzo NS, Ruiz JR, Hurtig-Wennlof A, Ortega FB, Sjostrom M. Relationship of physical activity, fitness, and fatness with clustered metabolic risk in children and adolescents: the European youth heart study. J Pediatr 2007; 150: 388394.
  • 10
    Lagou V, Manios Y, Moran CN et al. Developmental changes in adiposity in toddlers and preschoolers in the GENESIS study and associations with the ACE I/D polymorphism. Int J Obes (Lond) 2007; 31: 10521060.
  • 11
    Ruiz J, Blanché H, Cohen N et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994; 91: 36623665.
  • 12
    Singer DR, Missouris CG, Jeffery S. Angiotensin-converting enzyme gene polymorphism. What to do about all the confusion. Circulation 1996; 94: 236239.
  • 13
    Rigat B, Hubert C, Alhenc-Gelas F et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 13431346.
  • 14
    Kim S, Soltani-Bejnood M, Quignard-Boulange A et al. The adipose Renin-Angiotensin system modulates systemic markers of insulin sensitivity and activates the intrarenal Renin-Angiotensin system. J Biomed Biotechnol 2006; 2006: 27012.
  • 15
    Dwyer T, Blizzard L, Venn A et al. Syndrome X in 8-y-old Australian children: stronger associations with current body fatness than with infant size or growth. Int J Obes Relat Metab Disord 2002; 26: 13011309.
  • 16
    Jones G, Dwyer T. Bone mass in prepubertal children: gender differences and the role of physical activity and sunlight exposure. J Clin Endocrinol Metab 1998; 83: 42744279.
  • 17
    Dwyer T, Ponsonby AL, Newman NM, Gibbons LE. Prospective cohort study of prone sleeping position and sudden infant death syndrome. Lancet 1991; 337: 12441247.
  • 18
    D'Espaignet ET, Dwyer T, Newman NM, Ponsonby AL, Candy SG. The development of a model for predicting infants at high risk of sudden infant death syndrome in Tasmania. Paediatr Perinat Epidemiol 1990; 4: 422435.
  • 19
    Tanner JM, Whitehouse RH. Revised standards for triceps and subscapular skinfolds in British children. Arch Dis Child 1975; 50: 142145.
  • 20
    WHO Multicentre Growth Reference Study Group. Reliability of anthropometric measurements in the WHO Multicentre Growth Reference Study. Acta Paediatr Suppl 2006; 450: 3846.
  • 21
    Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412419.
  • 22
    Léger LA, Mercier D, Gadoury C, Lambert J. The multistage 20 metre shuttle run test for aerobic fitness. J Sports Sci 1988; 6: 93101.
  • 23
    van Mechelen W, Hlobil H, Kemper HC. Validation of two running tests as estimates of maximal aerobic power in children. Eur J Appl Physiol Occup Physiol 1986; 55: 503506.
  • 24
    Chiu KC, McCarthy JE. The insertion allele at the angiotensin I-converting enzyme gene locus is associated with insulin resistance. Metabolism 1997; 46: 395399.
  • 25
    De Stavola BL, Nitsch D, dos Santos Silva I et al. Statistical issues in life course epidemiology. Am J Epidemiol 2006; 163: 8496.
  • 26
    Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989; 79: 340349.
  • 27
    Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JC. ACE polymorphisms. Circ Res 2006; 98: 11231133.
  • 28
    Staessen JA, Ginocchio G, Wang JG et al. Genetic variability in the renin-angiotensin system: prevalence of alleles and genotypes. J Cardiovasc Risk 1997; 4: 401422.
  • 29
    Leiter LA, Lewanczuk RZ. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition. Am J Hypertens 2005; 18: 121128.
  • 30
    Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 13431350.
  • 31
    Kashiwagi A, Mott D, Bogardus C et al. The effects of short-term overfeeding on adipocyte metabolism in Pima Indians. Metabolism 1985; 34: 364370.
  • 32
    Dresner A, Laurent D, Marcucci M et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 1999; 103: 253259.
  • 33
    Engeli S, Schling P, Gorzelniak K et al. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 2003; 35: 807825.
  • 34
    Davi G, Guagnano MT, Ciabattoni G et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 2002; 288: 20082014.
  • 35
    Gorzelniak K, Engeli S, Janke J, Luft FC, Sharma AM. Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension. J Hypertens 2002; 20: 965973.
  • 36
    Zhang B, Tanaka H, Shono N et al. The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle. Clin Genet 2003; 63: 139144.
  • 37
    Montgomery HE, Clarkson P, Dollery CM et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 1997; 96: 741747.
  • 38
    Jandeleit-Dahm KA, Tikellis C, Reid CM, Johnston CI, Cooper ME. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. J Hypertens 2005; 23: 463473.
  • 39
    Scheen AJ. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials. Diabetes Metab 2004; 30: 487496.
  • 40
    Scheen AJ. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms. Diabetes Metab 2004; 30: 498505.
  • 41
    Hansson L, Lindholm LH, Niskanen L et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999; 353: 611616.